Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

764 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adjunct immunotherapies for tuberculosis.
Uhlin M, Andersson J, Zumla A, Maeurer M. Uhlin M, et al. Among authors: zumla a. J Infect Dis. 2012 May 15;205 Suppl 2:S325-34. doi: 10.1093/infdis/jis197. Epub 2012 Mar 29. J Infect Dis. 2012. PMID: 22457298 Review.
A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis.
Axelsson-Robertson R, Loxton AG, Walzl G, Ehlers MM, Kock MM, Zumla A, Maeurer M. Axelsson-Robertson R, et al. Among authors: zumla a. PLoS One. 2013;8(3):e58309. doi: 10.1371/journal.pone.0058309. Epub 2013 Mar 26. PLoS One. 2013. PMID: 23555576 Free PMC article. Clinical Trial.
Systems level immune response analysis and personalized medicine.
Brodin P, Valentini D, Uhlin M, Mattsson J, Zumla A, Maeurer MJ. Brodin P, et al. Among authors: zumla a. Expert Rev Clin Immunol. 2013 Apr;9(4):307-17. doi: 10.1586/eci.13.9. Expert Rev Clin Immunol. 2013. PMID: 23557267 Review.
Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
Bates M, Ahmed Y, Chilukutu L, Tembo J, Cheelo B, Sinyangwe S, Kapata N, Maeurer M, O'Grady J, Mwaba P, Zumla A. Bates M, et al. Among authors: zumla a. Trop Med Int Health. 2013 Sep;18(9):1134-1140. doi: 10.1111/tmi.12145. Epub 2013 Jul 3. Trop Med Int Health. 2013. PMID: 23834035 Free PMC article.
Rapid diagnostics urgently needed for killer infections.
Zumla A, Gant V, Bates M, Mwaba P, Maeurer M, Memish ZA. Zumla A, et al. Lancet Respir Med. 2013 Jun;1(4):284-5. doi: 10.1016/S2213-2600(13)70099-7. Epub 2013 May 20. Lancet Respir Med. 2013. PMID: 24429144 Free PMC article. Review. No abstract available.
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial.
Skrahin A, Ahmed RK, Ferrara G, Rane L, Poiret T, Isaikina Y, Skrahina A, Zumla A, Maeurer MJ. Skrahin A, et al. Among authors: zumla a. Lancet Respir Med. 2014 Feb;2(2):108-22. doi: 10.1016/S2213-2600(13)70234-0. Epub 2014 Jan 9. Lancet Respir Med. 2014. PMID: 24503266 Clinical Trial.
764 results